co.,

Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor ConferenceProfound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference

Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference

TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device…

3 weeks ago
Blue Point Brewing Co. Introduces Long Island Light: A Premium Craft LagerBlue Point Brewing Co. Introduces Long Island Light: A Premium Craft Lager

Blue Point Brewing Co. Introduces Long Island Light: A Premium Craft Lager

PATCHOGUE, N.Y., March 04, 2025 (GLOBE NEWSWIRE) -- Blue Point Brewing Company, Long Island’s original craft brewery and a Tilray…

3 months ago
Wojciech Podobas Increases Stake in Thinca Co., Ltd. (TSE: 149A) to 6.00% Following Tokyo VisitWojciech Podobas Increases Stake in Thinca Co., Ltd. (TSE: 149A) to 6.00% Following Tokyo Visit

Wojciech Podobas Increases Stake in Thinca Co., Ltd. (TSE: 149A) to 6.00% Following Tokyo Visit

DUBAI, United Arab Emirates, March 02, 2025 (GLOBE NEWSWIRE) -- Thinca Co., Ltd. (TSE: 149A), the developer and provider of…

3 months ago
Amita Desai & Co. merges with InCorp Global to form one of India’s leading Corporate Advisory FirmsAmita Desai & Co. merges with InCorp Global to form one of India’s leading Corporate Advisory Firms

Amita Desai & Co. merges with InCorp Global to form one of India’s leading Corporate Advisory Firms

Amita Desai to lead Corporate Secretarial Practice for InCorp Global in India as a Co-Founder MUMBAI, India, Feb. 19, 2025…

3 months ago
Elliott Statement on Tokyo Gas Co., Ltd.Elliott Statement on Tokyo Gas Co., Ltd.

Elliott Statement on Tokyo Gas Co., Ltd.

LONDON, Feb. 2, 2025 /PRNewswire/ -- Elliott Investment Management, L.P. and Elliott Advisors (U.K.) Limited ("Elliott," or "we"), which together advise…

3 months ago
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public OfferingPark Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering

Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering

Wuxi, China, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (the "Company"), a company focused on…

5 months ago